Abstract
The essence of the theoretical background of antidepressant action is based on the monoamine hypothesis of depression. It the 1960s it was noted that reserpine, a catecholamine-depleting agent, induced depression and that this effect was reversed by antidepressants.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Reuptake Inhibitor
- Sexual Dysfunction
- Selective Serotonin Reuptake Inhibitor
- Monoamine Oxidase Inhibitor
- Serotonin Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Anderson IM, Reid IC (eds). Fundamentals of Clinical Psychopharmacology, 3rd edn. London: Informa UK;2006.
Stahl SM. Essential Psychopharmacology. Cambridge: Cambridge University Press, 2006.
Shiloh R, Stryjer R, Nutt DJ (eds). Atlas of Psychiatric Pharmacotherapy, 2nd edn. London: Informa Healthcare;2005.
Yildiz A, Pauler DK, Sachs GS. Rates of study completion with single versus split daily dosing of antidepressants: a meta-analysis. J Affect Disord. 2004;78:157-162.
Yyldyz A, Sachs GS. Administration of antidepressants. Single versus split dosing: a metaanalysis. J Affect Disord. 2001;66:199-206.
British National Formulary. London: BMJ Publishing Group Ltd and RPS Publishing;2013.
Taylor D, Paton C, Kapur S (eds). The Maudsley Prescribing Guidelines, 11th edn. Chichester: Wiley-Blackwell; 2012.
Hawton K, Bergen H, Simkin S, Cooper J, Waters K, Gunnell D, Kapur N. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry. 2010 196:354-358.
Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs. 1999;57:507-533.
Food and Drug Administration (FDA). FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide). Safety Announcement [8-24-2011]. www.fda.gov/Drugs/DrugSafety/ucm269086.htm. Accessed December 19, 2013.
Haddad P, Dursan S, Deakin W (eds). Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. New York: Oxford University Press; 2004.
Anderson I, Ferrier I, Baldwin R, et al. Evidence-based guidelines foer treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2008;22:343-396.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer Healthcare
About this chapter
Cite this chapter
Friedman, E.S., Anderson, I.M. (2014). Medications. In: Handbook of Depression. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-79-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-907673-79-5_5
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-907673-78-8
Online ISBN: 978-1-907673-79-5
eBook Packages: MedicineMedicine (R0)